Actualización en Diabetes de Harvard 2025

Harvard Diabetes Update 2025

$ 74.99

  • Includes: videos + PDF

  • Target audience: Endocrinologists, primary care physicians, etc.

Course in English. Delivered via Google Drive, so a valid Gmail account is required. Does not include CME points or certificate.

SKU: VZA1G576 Categories: ,

Harvard Diabetes Update 2025
Diabetes Update will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.

All course content is in English. This product is shared via a Google Drive download link, so please provide your correct Gmail address when ordering. Please note that this course does not include CME points or certificate.

Training to meet the challenges of diabetes care

At a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?

The answer is rooted in four challenges:

  • Keeping pace with rapidly advancing clinical options for diabetes care:

    • Therapies

    • Technologies

    • Lifestyle medicine interventions

  • Designing comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications.

  • Accounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors.

  • Overcoming structural health care barriers that require clinical strategies to fit within a particular mold.

This course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.

Strategies, updates and best practices for state-of-the-art diabetes care.

This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.

Participants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:

  • Designing more effective treatment plans.

  • Current anti-diabetes medications and how to use them.

  • Diagnosis of different types of diabetes.

  • Utilization of recent technology advances in diabetes care.

  • Optimizing care for people with obesity.

  • Assessing and treating cardiovascular and renal complications.

  • Guiding patients on physical activity and medical nutrition.

  • Management of hypertension and dyslipidemia.

  • Addressing low engagement in therapy.

New data and practice guidelines for diabetes care

  • The newest data on the identification of different types of diabetes.

  • The latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes.

  • New guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care.

  • Criteria to navigate the controversial data related to some anti-diabetes medications.

  • Medical vs. surgical management of obesity.

  • New technologies in diabetes care: updates and implications for day-to-day care.

  • Research breakthroughs.

  • Tips and tricks for navigating barriers within health care systems.

Assessment and treatment of complications from diabetes

The 2025 program provides education to assess and treat:

  • Cardiovascular disease

  • Congestive Heart Failure

  • Renal Disease

  • Metabolic-Associated Steatotic Liver Disease

Optimizing health outcomes for diverse patient populations

This program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.

Coverage includes:

  • Racial and ethnic minorities

  • The elderly

  • People with obesity

  • Patients at high cardiovascular risk

  • Individuals with low engagement in therapy

  • Patients at low socio-economic levels

  • Subjects with low health literacy/education

  • Individuals with depression/emotional distress

  • Patients with metabolic liver disease

Program:

Date and Time Topic / Lecture Speaker(s)
Tuesday, April 29, 2025
9:00 – 9:15 Welcome and Introduction Course Directors
Identifying Various Types of Diabetes in Clinical Practice
9:15 – 9:40 Is It Type 1 Diabetes, Type 2 Diabetes, or Something Else? Miriam Udler, MD, PhD
9:40 – 10:05 The Connection Between Diabetes Phenotypes and Social Determinants of Health Jacqueline Seiglie, MD
10:05 – 10:45 Panel Discussion and Practical Recommendations Miriam Udler, MD, PhD and Jacqueline Seiglie, MD
10:45 – 11:00 Break
Medical Nutrition Management in Diabetes and Obesity
11:00 – 11:25 Does When You Eat Matter? Intermittent Fasting, Circadian Rhythms, and Food Order Courtney Peterson, PhD, MSc, MA, MS
11:25 – 11:50 Current Dietary Recommendations in Diabetes and Obesity Laura Andromalos, MS, RD, RN, CSOWM, CDCES
11:50 – 12:30 Panel Discussion and Practical Recommendations Courtney Peterson, PhD, MSc, MA, MS and Laura Andromalos, MS, RD, RN, CSOWM, CDCES
12:30 – 13:20 Break
Prescribing Exercise to Patients with Diabetes
13:20 – 13:45 Exercise Recommendations in Type 2 Diabetes and Obesity Edward M. Phillips, MD
13:45 – 14:10 A Practical Exercise Session Demonstration Jacqueline I. Shahar, MEd, RCEP, CDCES
14:10 – 14:50 Panel Discussion and Practical Recommendations Edward M. Phillips, MD and Jacqueline I. Shahar, MEd, RCEP, CDCES
14:50 – 15:00 Break
Special Lecture
15:00 – 15:45 Improving Diabetes Care by Addressing Patient, Health Care Professional, and Health Care System Factors A. Enrique Caballero, MD
Wednesday, April 30, 2025
9:00 – 9:10 Welcome, Recap, and Introduction to Day 2 Course Directors
Obesity Management in the Patient with Diabetes
9:10 – 9:40 Health Implications of Overweight and Obesity: A Focus on Sleep Disorders Peminda Cabandugama, MD, DABOM
9:40 – 10:10 Lifestyle Modification in Obesity: Does It Work? Julia Lloyd, MPH, RD, CDCES
10:10 – 10:50 Pharmacological Management: What Intervention and When? W. Scott Butsch, MD, MSc
10:50 – 11:05 Break
11:05 – 11:35 Surgical Management of Obesity: An Update Matthew M. Hutter, MD, MBA, MPH
11:35 – 12:15 Panel Discussion and Practical Recommendations W. Scott Butsch, MD, MSc, Matthew M. Hutter, MD, MBA, MPH, and Julia Lloyd, MPH, RD, CDCES
12:15 – 13:05 Break
Management of Traditional CV Risk Factors in Diabetes
13:05 – 13:45 Dyslipidemia Management in the Patient with Diabetes Om P. Ganda, MD
13:45 – 14:30 Hypertension Management in the Patient with Diabetes Naomi D. Fisher, MD
14:30 – 15:00 Q and A and Practical Recommendations Om P. Ganda, MD and Naomi D. Fisher, MD
Special Lecture
15:00 – 15:45 Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2025 Vision Kenneth Cusi, MD
Thursday, May 1, 2025
9:00 – 9:10 Welcome, Recap, and Introduction to Day 3 Course Directors
Cardiovascular Disease in the Patient with Diabetes
9:10 – 9:40 Coronary Artery Disease: Evaluation and Management Jorge Plutzky, MD
9:40 – 10:10 Heart Failure in the Patient with Diabetes: An Update Deepak L. Bhatt, MD, MPH, MBA
10:10 – 10:45 Q and A and Practical Recommendations Jorge Plutzky, MD and Deepak L. Bhatt, MD, MPH, MBA
10:45 – 11:00 Break
Renal Disease in the Patient with Diabetes
11:00 – 11:25 Evaluation of Chronic Kidney Disease Katherine R. Tuttle, MD
11:25 – 11:50 Prevention and Management of Chronic Kidney Disease Janani Rangaswami, MD, FACP, FCRS, FAHA
11:50 – 12:30 Q and A and Practical Recommendations Katherine R. Tuttle, MD and Janani Rangaswami, MD, FACP, FCRS, FAHA
12:30 – 13:20 Break
Technology Advances in Diabetes Care
13:20 – 13:50 Continuous Glucose Monitoring: A 2025 Vision Devin Steenkamp, MD
13:50 – 14:20 Insulin Pumps, Closing the Loop: Where Do We Stand? Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
14:20 – 14:50 Q and A and Practical Recommendations Devin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
14:50 – 15:00 Break
Special Lecture
15:00 – 15:45 Artificial Intelligence in Diabetes Care: Fact or Fiction? James Flory, MD
Friday, May 2, 2025
9:00 – 9:10 Welcome, Recap, and Introduction to Day 4 Course Directors
Pharmacological Management of Type 2 Diabetes: Traditional Medications
9:10 – 9:50 Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors) Deborah J. Wexler, MD, MPH
9:50 – 10:30 Insulin Therapy in the Patient with Diabetes Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
10:30 – 11:10 Q and A and Practical Recommendations Deborah J. Wexler, MD, MPH and Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
11:10 – 11:20 Break
Special Lecture
11:20 – 12:00 Lack of Adherence to Therapy and Clinical Inertia: How to Overcome Them Anne Peters, MD
12:00 – 13:00 Break
Pharmacological Management of Type 2 Diabetes: Newer Medications
13:00 – 13:35 SGLT-2 Inhibitors: An Update Silvio E. Inzucchi, MD
13:35 – 14:10 GLP-1 Receptor Agonists: An Update Lee-Shing Chang, MD
14:10 – 14:45 Mineralocorticoid Receptor Antagonists: Role in Diabetes Care Romela Petrosyan, MD
14:45 – 15:30 Q and A and Practical Recommendations Silvio E. Inzucchi, MD, Lee-Shing Chang, MD, and Romela Petrosyan, MD
15:30 – 15:40 Closing Remarks Course Directors

Reviews

There are no reviews yet.

Be the first to review “Actualización en Diabetes de Harvard 2025”

Your email address will not be published. Required fields are marked *

Related products